热门资讯> 正文
Quoin Pharmaceuticals宣布内部股票购买
2024-09-09 21:08
- Quoin Pharmaceuticals (NASDAQ:QNRX) has announced that its CEO, Michael Myers, and COO, Denise Carter, have recently made significant purchases of the Co.’s ADSs, signaling their confidence in the company’s growth and direction.
- On Sept. 3 and 4, 2024, Michael Myers, CEO of Quoin Pharmaceuticals, acquired a total of 37,894 ADSs at prices ranging from $0.619 to $0.7974 per ADS.
- Similarly, COO Denise Carter acquired a total of 37,735 ADSs between September 3 and 4, 2024, at prices between $0.6253 and $0.7965 per ADS.
- QNRX +5% premarket to $0.81.
More on Quoin Pharmaceuticals
- Seeking Alpha’s Quant Rating on Quoin Pharmaceuticals
- Historical earnings data for Quoin Pharmaceuticals
- Financial information for Quoin Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
